Key drivers for each region include: for North America, adoption of advanced guidewire technologies, established healthcare infrastructure, and high demand for minimally invasive procedures; for Europe, stringent regulatory policies, investments in research and development, and growing awareness of neurointerventional treatments; for Asia Pacific, rapidly expanding healthcare ecosystem, increasing demographics with neurological disorders, and improving infrastructure; for Latin America, growing demand for neurointerventional procedures, policies supporting healthcare development, and rising investments in medical technology; and for Middle East & Africa, emerging healthcare markets, adopting advanced neurointerventional technologies, and rising awareness of neurointerventional treatments.